These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1647670)

  • 21. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction.
    Lundberg JM; Hemsén A; Larsson O; Rudehill A; Saria A; Fredholm BB
    Eur J Pharmacol; 1988 Jan; 145(1):21-9. PubMed ID: 2832184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
    Widdowson PS; Halaris AE
    Brain Res; 1991 Jan; 539(2):196-202. PubMed ID: 1647239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland.
    Torda T; Cruciani RA; Saavedra JM
    Neuroendocrinology; 1988 Aug; 48(2):207-10. PubMed ID: 2851754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y receptor in vascular smooth muscle.
    Shigeri Y; Mihara S; Fujimoto M
    J Neurochem; 1991 Mar; 56(3):852-9. PubMed ID: 1847185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiographic localization of receptors for neuropeptide Y (NPY) in the brain of broiler and leghorn chickens (Gallus domesticus).
    Merckaert J; Vandesande F
    J Chem Neuroanat; 1996 Dec; 12(2):123-34. PubMed ID: 9115667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.
    Balasubramaniam A; Sheriff S
    J Biol Chem; 1990 Sep; 265(25):14724-7. PubMed ID: 2168390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of putatively irreversible antagonists with beta 1- and beta 2-adrenergic receptors.
    Minneman KP; Mowry CB
    Biochem Pharmacol; 1986 Mar; 35(5):857-64. PubMed ID: 2869757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of liver and cerebellar binding sites for avian pancreatic polypeptide.
    Adamo ML; Hazelwood RL
    Endocrinology; 1990 Jan; 126(1):434-40. PubMed ID: 2293998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
    Singh G; Singh L; Raufman JP
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease.
    Martel JC; Alagar R; Robitaille Y; Quirion R
    Brain Res; 1990 Jun; 519(1-2):228-35. PubMed ID: 2168782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of neuropeptide Y receptors in rabbit kidney: preliminary comparisons with rat and human kidney.
    Schachter M; Miles CM; Leys K; Sever PS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S157-62. PubMed ID: 2455171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
    Krause J; Eva C; Seeburg PH; Sprengel R
    Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y; Nishi N; Nakagawa S; Koyama T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide Y. Differential binding to rat intestinal laterobasal membranes.
    Nguyen TD; Heintz GG; Kaiser LM; Staley CA; Taylor IL
    J Biol Chem; 1990 Apr; 265(11):6416-22. PubMed ID: 2156850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 125I-neuropeptide Y binding activity of pig spleen cell membranes: effect of solubilisation.
    Price JS; Brown MJ
    Life Sci; 1990; 47(24):2299-306. PubMed ID: 1702499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of peptide YY receptors in the brain.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Shii K; Yokono K; Mizuno N; Baba S
    Endocrinology; 1989 Jan; 124(1):402-9. PubMed ID: 2535812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the structural requirement for ligand binding to the neuropeptide Y (NPY) receptor from rat cerebral cortex.
    Baeza CR; Undén A
    FEBS Lett; 1990 Dec; 277(1-2):23-5. PubMed ID: 2176616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-linking of neuropeptide Y to its receptor on rat brain membranes.
    Mannon PJ; Taylor IL; Kaiser LM; Nguyen TD
    Am J Physiol; 1989 Mar; 256(3 Pt 1):G637-43. PubMed ID: 2538077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.